There were 1,437 press releases posted in the last 24 hours and 466,791 in the last 365 days.

BioBanking 2016: ensuring compliance through regulatory updates and impact on industry

6th BioBanking Conference

SMi Group reports (18.03.2016, London, UK) EU regulatory bodies and big pharma to discuss the future of biobanking industry

The two-day agenda will address legislation challenges, explore key advancements in R&D and sampling, discuss the commercialisation of biobanking and harmonisation between biobanks across the world.
— SMi Group
LONDON, SELECT STATE/PROVINCE, UNITED KINGDOM, March 18, 2016 /EINPresswire.com/ -- At the forefront of Biobanking shows, SMi’s 6th Biobanking conference returns to London on 20th – 21st June at the Holiday Inn Kensington Forum. Registration is now live on http://www.bio-banking-event.com/ein.

The unmissable conference and exhibition will once again gather a global audience of leading industry experts including regulatory decision-makers, scientific researchers, and academia, providing the perfect platform to explore the latest developments and ethical guidelines in biobanking processes to improve R&D outcomes.

The expert speaker panel includes:
• Octavi Quintana Trias, Principal Advisor for the Directorate-General, European Commission
• Professor Glyn Stacey, Director, UK Stem Cell Bank, Division of Advanced Therapies, National Institute for Biological Standards and Control – MHRA
• Emma Snapes, Biobank Manager, Infant Biobank
• Dr Brian Thomson, Director and Clinical Lead for 100K Genome Project, Nottingham Health Science Biobank
• Dr Julia Riedlinger, Head of Marker Scouting and Sample Bank, Roche Diagnostics
• Arthur Lewis, Senior R&D Manager, MedImmune
• Dr Michael Luntang-Jensen, Biobank Manager, H. Lundbeck A/S
• Jonathan Sellors, Legal Counsel, UK Biobank

Proposed changes to EU’s new Data Protection Act will constitute a new legal framework for biobanking operations if and once passed by the European Commission. As such, this year’s conference will have a major focus on the potential changes and its impacts on the ethical and regulatory landscape of the biobanking industry, in addition to hearing from a selection of leading European biobanks currently adding value to clinical research through successful strategies.

The two-day agenda will address legislation challenges, explore key advancements in R&D and sampling, and discuss the commercialisation of biobanking whilst maintaining sustainability and harmonisation between biobanks across the world.
The complete conference agenda including speakers and their topics as well as registration details can be found at www.bio-banking-event.com. A £400 discount applies to online bookings made by 31st March 2016.

This unmissable and timely conference is CPD-certified.

For tailored sponsorship and branding and exhibition opportunities, contact Alia Malick at +44 (0) 7827 6168 or email amalick@smi-online.co.uk.

6th BioBanking Conference and Exhibition
London, UK
20-21 June 2016
http://www.bio-banking-event.com/ein

------------------------- END --------------------------
About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Honey de Gracia
SMi
02078276184
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.